DEUTSCHE BANK AG\ - ASLAN PHARMACEUTICALS LTD ownership

ASLAN PHARMACEUTICALS LTD's ticker is ASLN and the CUSIP is 04522R101. A total of 7 filers reported holding ASLAN PHARMACEUTICALS LTD in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of ASLAN PHARMACEUTICALS LTD
ValueSharesWeighting
Q1 2020$1,000
-75.0%
1,185
-44.9%
0.00%
Q4 2019$4,000
+33.3%
2,151
-0.9%
0.00%
Q3 2019$3,0002,1710.00%
Other shareholders
ASLAN PHARMACEUTICALS LTD shareholders Q3 2019
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 1,498,192$1,678,0000.68%
TANG CAPITAL MANAGEMENT LLC 2,054,925$2,302,0000.46%
Sio Capital Management, LLC 1,270,758$1,423,0000.43%
DAFNA Capital Management LLC 732,500$820,0000.21%
Vivo Capital, LLC 2,840,909$3,182,0000.19%
MANGROVE PARTNERS IM, LLC 2,514,576$2,816,0000.17%
SABBY MANAGEMENT, LLC 899,850$1,008,0000.15%
Waterfront Wealth Inc. 270,000$302,0000.12%
Knott David M Jr 230,251$258,0000.09%
RTW INVESTMENTS, LP 3,250,000$3,640,0000.05%
View complete list of ASLAN PHARMACEUTICALS LTD shareholders